Dados B3 › SCAR3 × PEAB3
SCAR3 × PEAB3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | SCAR3 | PEAB3 | year |
|---|---|---|---|
| ROE | 4.9% | 0.0% | 2025 |
| ROIC | 2.6%! | 3.2% | 2025 |
| ROA | -1.6% | 2.7% | 2025 |
| Gross margin | 48.8% | 40.7% | 2025 |
| EBIT margin | 26.2% | 26.4% | 2025 |
| Net margin | -16.2% | 28.7% | 2025 |
| Net debt/EBITDA | 3.23x | -0.11x | 2025 |
| Current ratio | 1.78x | 3.34x | 2025 |
| Revenue growth (1y) | -41.1% | 33.8% | 2025 |
| Revenue growth (5y CAGR) | -2.6% | 34.3% | 2025 |
| Piotroski F-Score | 3/9 | 3/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | SCAR3 | PEAB3 | year |
|---|---|---|---|
| P/E | 12.57x | — | 2025 |
| P/B | 0.76x | 0.83x | 2025 |
| EV/EBITDA | 9.39x | 15.60x | 2025 |
| FCF yield | -21.2% | -6.2% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 10:03 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 10:03 UTC. If this does not match /saude, you are reading a cached copy.